Evidence map›Paper›PMID 37081718›Full record

ArticleCancer medicine2023

Communication transforms the impact of the COVID-19 pandemic on children with cancer and their families.

Gia Ferrara, Molly Aguina, Emily Mirochnick, Parima Wiphatphumiprates, Daniel C Moreira, Elizabeth Sniderman, César A Villegas, Erica C Kaye, Iman Ragab, Biemba Maliti and 13 more

Abstract read
In one paragraph

Article in Cancer medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Gia FerraraSt. Jude Children's Research Hospital, Memphis, Tennessee, USA.ORCID 0000-0002-3435-8436
Molly AguinaPrinceton University, Princeton, New Jersey, USA.
Emily MirochnickThe Chicago Medical School at Rosalind Franklin University of Medicine and Science, North Chicago, Illinois, USA.ORCID 0000-0001-7437-1654
Parima WiphatphumipratesRhodes College, Memphis, Tennessee, USA.
Daniel C MoreiraSt. Jude Children's Research Hospital, Memphis, Tennessee, USA.ORCID 0000-0003-4082-156X
Elizabeth SnidermanNorthern Alberta Children's Cancer Program, Stollery Children's Hospital, Edmonton, Alberta, Canada.ORCID 0000-0001-6004-6068
César A VillegasSt. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Erica C KayeSt. Jude Children's Research Hospital, Memphis, Tennessee, USA.ORCID 0000-0002-6522-3876
Iman RagabAin Shams University, Children's Hospital, Hematology-Oncology Unit, Cairo, Egypt.
Biemba MalitiCancer Diseases Hospital, Lusaka, Zambia.
Gita NaiduChris Hani Baragwanath Academic Hospital, University of the Witwatersrand, Johannesburg, South Africa.
Pascale Y GassantHospital Saint-Damien, Port-au-Prince, Haiti.
Daniela ArceHospital Pediátrico de Sinaloa, Culiacan, Mexico.
Ramandeep Singh AroraMax Super Specialty Hospital, New Delhi, India.
Ana Patricia AlcasabasUniversity of the Philippines, Philippine General Hospital, Manila, Philippines.
Muhammad Rafie RazaThe Indus Hospital, Karachi, Pakistan.
Pablo VelascoPediatric Oncology and Hematology Department, Vall d'Hebron Hospital, Barcelona, Spain.
Joyce KambuguUganda Cancer Institute, Kampala, Uganda.
Anna VinitskySt. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Carlos Rodriguez GalindoSt. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Asya AgulnikSt. Jude Children's Research Hospital, Memphis, Tennessee, USA.ORCID 0000-0001-8932-8181
Dylan E GraetzSt. Jude Children's Research Hospital, Memphis, Tennessee, USA.ORCID 0000-0002-4541-6910
COVIMPACT study group

Funding

Viral Vector Technology (VVTSR)P30CA021765 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI CHARLES ROBERTS · 1985 to 2026
$166.9M
PROFESSIONAL ONCOLOGY EDUCATION PROGRAMR25CA023944 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI SUZANNE A. GRONEMEYER · 1986 to 2026
$8.3M
NCI NIH HHS P30 CA021765NCI NIH HHS R25 CA023944
6 · The paper itself

Abstract

backgroundThe COVID-19 pandemic altered healthcare systems globally, causing delays in care delivery and increased anxiety among patients and families. This study examined how hospital stakeholders and clinicians perceived the global impact of the COVID-19 pandemic on children with cancer and their families.

methodsThis secondary analysis examined data from a qualitative study consisting of 19 focus groups conducted in 8 languages throughout 16 countries. A codebook was developed with novel codes derived inductively from transcript review. In-depth analysis focused on the impact of the COVID-19 pandemic on children with cancer and their families.

resultsEight themes describing the impact of the pandemic on patients and their families were identified and classified into three domains: contributing factors (COVID-19 Policies, Cancer Treatment Modifications, COVID-19 Symptoms, Beliefs), patient-related impacts (Quality of Care, Psychosocial impacts, Treatment Reluctance), and the central transformer (Communication). Participants described the ability of communication to transform the effect of contributing factors on patient-related impacts. The valence of impacts depended on the quality and quantity of communication among clinicians and between clinicians and patients and families.

conclusionsCommunication served as the central factor impacting whether the COVID-19 pandemic positively or negatively affected children with cancer and families. These findings emphasize the key role communication plays in delivering patient-centered care and can guide future development of communication-centered interventions globally.

Indexed as

COVID-19NeoplasmsChildCommunicationHumansLanguagePandemicsclinical cancer researchpediatric cancerpsychosocial studiesquality of life

Identifiers

PMID37081718
PMCPMC10278468

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.